Switching from Sitagliptin to Liraglutide in Subjects with Type 2 Diabetes (T2D): Analysis of Composite Endpoints from the LIRA-SWITCH Randomized Trial

Autor:	Paturi V. Rao, Sidsel B. Christensen, Margit S Kaltoft, Francisco J. Tinahones, R Takács, George M. Tsoukas, Maximo Maislos, Damir Boras, Timothy S. Bailey
Rok vydání:	2016
Předmět:	medicine.medical_specialty business.industry Liraglutide Endocrinology Diabetes and Metabolism Lira General Medicine Type 2 diabetes medicine.disease law.invention Endocrinology Randomized controlled trial law Internal medicine Sitagliptin Internal Medicine Medicine business medicine.drug
Zdroj:	Canadian Journal of Diabetes. 40:S39-S40
ISSN:	1499-2671
DOI:	10.1016/j.jcjd.2016.08.112
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e95a808595ffd2cd87f4026e8799cbce https://doi.org/10.1016/j.jcjd.2016.08.112 Zobrazit plný text záznamu Full Text from ScienceDirect